Humana Inc. (LON:0J6Z)
London
· Delayed Price · Currency is GBP · Price in USD | Market Cap | 24.99B |
| Revenue (ttm) | 89.86B |
| Net Income (ttm) | 1.15B |
| Shares Out | n/a |
| EPS (ttm) | 9.52 |
| PE Ratio | 21.73 |
| Forward PE | 18.35 |
| Dividend | 2.70 (1.00%) |
| Ex-Dividend Date | Jun 27, 2025 |
| Volume | 141 |
| Average Volume | 615 |
| Open | 277.00 |
| Previous Close | 270.17 |
| Day's Range | 275.53 - 281.42 |
| 52-Week Range | 203.84 - 381.74 |
| Beta | 0.45 |
| RSI | 68.76 |
| Earnings Date | Jul 30, 2025 |
About Humana
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. It offers medical care and supplemental benefit plans to individuals. The company also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, it provides commercial fully-insured medical a... [Read more]
Financial Performance
In 2024, Humana's revenue was $117.76 billion, an increase of 10.70% compared to the previous year's $106.37 billion. Earnings were $1.21 billion, a decrease of -51.51%.
Financial numbers in USD Financial StatementsNews
Humana and DrFirst Partner on Innovation to Fill Gaps in Care, Improve Outcomes for Patients with Diabetes and Other Chronic Conditions
Program Designed to Increase Use of Recommended Medication Therapy by Connecting with Providers in Workflow LOUISVILLE, Ky. and ARLINGTON, Va.
Is the Market Bullish or Bearish on Humana?
Humana's (NYSE: HUM) short percent of float has risen 9.8% since its last report. The company recently reported that it has 4.68 million shares sold short , which is 4.37% of all regular shares that ...
HUMANA (HUM) ALERT: Bragar Eagel & Squire, P.C. is Investigating Humana Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Attorney Brandon Walker Encourages Investors Who Suffered Losses In Humana (HUM) To Contact Him Directly To Discuss Their Options
Humana (HUM) Q2 Revenue Rises 10%
Humana raises 2025 EPS outlook to $17 with CenterWell and MA outperformance while advancing cost efficiency
Humana Inc. (HUM) Q2 2025 Earnings Call Transcript
Top Stock Movers Now: Humana, Hershey, VF Corp., and More
U.S. equities were mixed at midday with the market reacting to a strong report on the U.S. economy while awaiting the Federal Reserve's interest rate decision.
Humana Boosts Outlook on Lower-Than-Expected Medicare Advantage Membership Drop
Humana raised its full-year outlook as it anticipates a smaller decline in Medicare Advantage membership than originally expected.
Humana Boosts 2025 Profit Guidance, Plans $100 Million In Strategic Investments
As the healthcare landscape evolves with new legislation and shifting demographics, Humana Inc. (NYSE: HUM) is adapting to these changes through strategic adjustments. This adaptability is reflected ...
Humana Boosts 2025 Profit Guidance, Plans $100 Million In Strategic Investments
As the healthcare landscape evolves with new legislation and shifting demographics, Humana Inc. HUM is adapting to these changes through strategic adjustments. This adaptability is reflected in their ...
Has Humana turned the corner? Stock jumps as outlook raised, Medicare business improves
Humana’s stock surges, after the health insurer raises its full-year profit outlook and sees improvement in its Medicare Advantage business.
Humana gains as Medicare and CenterWell units drive guidance raise
Humana Stock Pops After Earnings Beat, Guidance Hike
Humana Raises 2025 Outlook as Revenue Tops Estimates
Insurer Humana raises annual profit forecast, shares climb
Humana raised its annual profit forecast on Wednesday, as the U.S. health insurer bets on its efforts to rein in higher medical costs that have plagued the sector, sending its shares up nearly 6% in p...
Humana reports mixed Q2 results; updates FY25 outlook
Humana Reports Second Quarter 2025 Financial Results; Raises Full Year 2025 Adjusted EPS and Revenue Guidance
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended June 30, 2025 (2Q25) versus the quarter ...
Humana Q2 2025 Earnings Preview
Evercore ISI's Umer Raffat on finding value in the beaten-down health care sector
Umer Raffat, Evercore ISI senior analyst, joins 'The Exchange' to discuss if there's a turnaround coming for the health care sector.
Centene, Cigna, Others Drop As Molina's Results Rattle Sector
Molina Healthcare Inc. (NYSE: MOH) missed Wall Street expectations in its second-quarter earnings report Wednesday, triggering a selloff across the healthcare insurance sector . Shares of Alignment H...
Centene, Cigna, Others Drop As Molina's Results Rattle Sector
Molina Healthcare Inc. MOH missed Wall Street expectations in its second-quarter earnings report Wednesday, triggering a selloff across the healthcare insurance sector.
Fortune 100 health insurer Humana commits to ‘greater transparency’ on pre-approval as it slashes a third of all mandates
Prior authorization is a process health insurers use to determine whether they will cover a prescription, medical procedure, or service.
Humana Moves To Cut Prior Authorization Delays, Streamline Care Approvals
Humana Inc. NYSE: HUM) on Tuesday announced accelerated efforts to approve care requests as quickly as possible and reduce the administrative burden for physicians associated with prior authorization.